Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ETHA vs GSK✓SelectedUSD · GSKETHA vs GSK performance historyLatest closeAs of-9.16%11/20
Stock and ETF performance explorer

ETHA vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-54.1%
GSK return
+34.3%
Excess return
-88.4%
Maximum drawdown
-67.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-9.2%-0.1%-9.0%-9.2%
7D-18.0%-5.3%-12.7%-17.7%
30D-36.0%-3.7%-32.4%-35.9%
3M-31.4%-7.3%-24.2%-31.1%
6M-25.4%-4.2%-21.2%-25.4%
YTD-46.4%+0.9%-47.2%-46.6%
1Y-43.8%+7.3%-51.1%-44.4%
All-54.1%+34.3%-88.4%-62.0%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling